v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Matterport
Stockholders’ Equity Attributable to CoStar Group
Stockholders’ Equity Attributable to CoStar Group
Matterport
Common Stock
Common Stock
Matterport
Additional Paid-In Capital
Additional Paid-In Capital
Matterport
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Equity Attributable to NCI
Beginning balance (in shares) at Dec. 31, 2024         409.5              
Beginning balance at Dec. 31, 2024     $ 7,553   $ 4   $ 5,232     $ (26) $ 2,343 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) $ (15)   (15)               (15)  
Other comprehensive income 9   9             9    
Exercise of stock options (in shares)         0.1              
Exercise of stock options 1   1       1          
Restricted stock grants (in shares)         2.3              
Restricted stock grants surrendered (in shares)         (0.3)              
Restricted stock grants surrendered     (34)       (34)          
Employee stock purchase plan (in shares)         0.1              
Employee stock purchase plan     6       6          
Management stock purchase plan     (1)       (1)          
Stock-based compensation expense     30       30          
Stock repurchases under stock repurchase programs (in shares)         (0.2)              
Stock repurchases under stock repurchase programs (18)   (18)           $ (18)      
Common stock issued for Matterport Acquisition (in shares)           11.7            
Common stock issued for Matterport acquisitions and Domain acquisition   $ 1,025   $ 1,025       $ 1,025        
Ending balance (in shares) at Mar. 31, 2025         423.2              
Ending balance at Mar. 31, 2025     8,556   $ 4   6,259   (18) (17) 2,328 0
Beginning balance (in shares) at Dec. 31, 2024         409.5              
Beginning balance at Dec. 31, 2024     7,553   $ 4   5,232     (26) 2,343 0
Ending balance (in shares) at Dec. 31, 2025         417.9              
Ending balance at Dec. 31, 2025 8,371   8,334   $ 4   6,410   (510) 80 2,350 37
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) 3   3               3  
Other comprehensive income 51   51             51    
Change in NCI 1                     1
Exercise of stock options (in shares)         0.9              
Exercise of stock options 8   8       8          
Restricted stock grants (in shares)         0.1              
Restricted stock grants surrendered (in shares)         (0.6)              
Restricted stock grants surrendered (20)   (20)       (20)          
Employee stock purchase plan (in shares)         0.1              
Employee stock purchase plan 7   7       7          
Management stock purchase plan (in shares)         0.1              
Management stock purchase plan (2)   (2)       (2)          
Stock-based compensation expense 41   41       41          
Stock repurchases under stock repurchase programs (in shares)         (11.4)              
Stock repurchases under stock repurchase programs (509)   (509)       (3)   (506)      
Ending balance (in shares) at Mar. 31, 2026         407.1              
Ending balance at Mar. 31, 2026 $ 7,951   $ 7,913   $ 4   $ 6,441   $ (1,016) $ 131 $ 2,353 $ 38